Potentiating and correcting mutant CFTR in patients with cystic fibrosis

Isabelle Sermet-Gaudelus, Jacques de Blic, Muriel LeBourgeois, Iwona Pranke, Aleksander Edelman, Bonnie W. Ramsey

Source: Eur Respir Monogr 2014; 64: 129-149
Journal Issue: Cystic Fibrosis
Disease area: Paediatric lung diseases

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Isabelle Sermet-Gaudelus, Jacques de Blic, Muriel LeBourgeois, Iwona Pranke, Aleksander Edelman, Bonnie W. Ramsey. Potentiating and correcting mutant CFTR in patients with cystic fibrosis. Eur Respir Monogr 2014; 64: 129-149

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
Source: ERJ Open Res, 5 (2) 00082-2019; 10.1183/23120541.00082-2019
Year: 2019



CFTR: cystic fibrosis and beyond
Source: Eur Respir J 2014; 44: 1042-1054
Year: 2014



Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation
Source: Eur Respir Rev 2013; 22: 66-71
Year: 2013



Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
Source: Eur Respir Rev 2013; 22: 58-65
Year: 2013



A novel CFTR mutation found in a Chinese cystic fibrosis patient
Source: Eur Respir J 2005; 26: Suppl. 49, 402s
Year: 2005

Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease
Source: Eur Respir J 2009; 34: 772
Year: 2009


Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019
Year: 2021



Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006

CFTR gene mutations detected in Japanese individuals with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 716s
Year: 2006

Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2016; 47: 322-324
Year: 2016


Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients
Source: Eur Respir J 2004; 23: 679-684
Year: 2004



Analysis of CFTR gene mutations in 24 Japanese individuals with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010


Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Distinctive CFTR gene mutations found in Japanese individuals with cystic fibrosis
Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems
Year: 2004


Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient
Source: Eur Respir J 2002; 19: 374-376
Year: 2002



Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
Source: Eur Respir J 2016; 48: 451-458
Year: 2016



The effect of CFTR modulators on CT outcomes in cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019